Chinese earth tiger tarantula venom-derived Nav1.7 inhibitory peptides (Amgen Inc)

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug NameChinese earth tiger tarantula venom-derived Nav1.7 inhibitory peptides (Amgen Inc)
Drug Alias NameJzTx-V-derived Nav1.7 inhibitory peptides (Amgen Inc)AM-0422AM-6120AM-8145
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionSodium channel protein type IX alpha subunit blockers
TargetsSodium channel protein type IX alpha subunit
Therapy Area/IndicationsPain
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAmgen Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAmgen Inc
Active IndicationsN/A
Inactive IndicationsPain

Other Information

ATC CodeN/A
Related LinksN/A